What podcasts say about biotech
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about biotech
7 statements · 3 positive · 1 negative · 2 mixed · 1 neutral
Sustained rising interest rates generally create difficult conditions for biotech.
“when you're in a secularly rising rate environment in general, tough for biotech.”
Open the episode · AI Boom Reality Check, Jobs Boom, Cybertruck Scrapped | Praveer Melwani, Keller Cliffton, Rahul Sonwalkar, Max Siegelman, D.A. WallachListen at 1:56:46
Biotech investing requires specialized knowledge and careful selection.
“I think biotech, you really have to know what you're doing and you have to pick your spots very carefully.”
Open the episode · Why the traditional 60/40 portfolio might be deadListen at 23:02
Biotech investment performance is highly dispersed across companies and ETFs.
“Biotech is much more dispersed.”
Open the episode · Market Bounces To Cap Strong Week For Growth; Microsoft, Amphenol, Bloom Energy, Micron In FocusListen at 16:34
Biotech remains worth examining despite XBI’s weakness.
“this is an area that I think, despite XBI, I think is still definitely worth looking at.”
Open the episode · Market Bounces To Cap Strong Week For Growth; Microsoft, Amphenol, Bloom Energy, Micron In FocusListen at 16:45
Biotech is a speculative investment rather than a defensive one.
“Biotech is more of like a speculative investment”
Open the episode · A Breakthrough Cancer Vaccine Fueled a Biotech Rally. Can It Last?Listen at 17:02
Biotech activity is expected to continue strengthening.
“we would anticipate that biotech continues to strengthen”
Open the episode · Mad Money w/ Jim Cramer 4/23/26Listen at 24:03
Biotech stocks have been performing exceptionally well
“biotech has been on fire”
Open the episode · Mad Money w/ Jim Cramer 1/9/26Listen at 28:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.